CH 20: Hematologic Disorders Flashcards
two components of blood
Plasma: contains water, solutes, nutrients, and proteins
Blood cells: contains erythrocytes, leukocytes, and thrombocytes
how much blood in average human
There are about 5 to 6 quarts (4.7-5.5L) of blood in the average adult who weighs between 150 and 180 pounds.
thromocytes are responsible for:
clotting
Leukocytes are responsible for:
fighting infection
erythrocytes are responsible for:
carrying oxygen
where do we find iron
Storage in bones
ingestion
transporting
RBC
Recycling
RBC diagnostics
Hemoglobin
Measures gas-carrying capacity of RBC
Female: 12-16 g/dL
Male: 14-18 g/dL
Increased: polycythemia vera, hemoconcentration (dehydration)
Decreased: anemia, blood loss, bone marrow suppression
Hematocrit
Percent of RBCs compared to total blood volume
3x Hgb
Female: 37-47%
Male: 42-52%
Increased: polycythemia vera, hemoconcentration (dehydration)
Decreased: anemia, blood loss, bone marrow suppression
RBC
Number of circulating RBCs
Female: 4.2-5.4 x 106/µL
Male: 4.7-6.1 x 106/µL
Increased: high altitude, polycythemia
Decreased: anemia, blood loss, bone marrow suppression
RBC Morphology
Examines shape and size of RBC
No variation
Aids to determine type of anemia
RBC indices
special indicators that reflect RBC volume, color, and hemoglobin saturation
MCV: 80-95 fL
MCH: 27-31 pg
MCHC: 32-36%
Increased MCV/MCH: pernicious anemia and folic acid deficiencies
Decreased MCV/MCH: iron-deficiency anemia, lead poisoning
Decreased MCHC: iron-deficiency anemia
Erythrocyte sedimentation rate (ESR)
Measures sed rate of RBCs;
<20 mm/hr
Increased: inflammatory process
platelet diagnostic labs
Platelets
Number of circulating platelets
150,000 – 400,000
Increased: polycythemia, thrombocytosis (excessive clotting)
Decreased: thrombocytopenia, suppressed bone marrow, autoimmune disease, splenomegaly; increased risk of bleeding
PT
Assess extrinsic coagulation and response to warfarin therapy
10-15 secs
Prolonged PT: deficiencies in clotting factors, anticoag therapy
Decreased time: vitamin K excess
aPTT
Assess intrinsic coagulation and response to heparin therapy
30-40 secs
Prolonged: insufficiency of clotting factors, presence of heparin, fibrinolysis
INR
Compares PT with control value; measures effectiveness of warfarin
0.8 – 1.1 without warfarin; 2.5 – 3.5 with warfarin
Increased: DIC, cirrhosis, hepatitis, vit K deficiency, salicylate intoxication, supratherapeutic for warfarin therapy
D-dimer
Measures fragment of fibrin that forms b/c of degradation or clot lysis
< 250ng/mL
Increased: hypercoagulable states (PE, DIC)
iron diagnostic labs
Serum iron
Amount of protein-bound iron in circulation
Female: 60-160 mcg/dL
Male: 80-180 mcg/dL
Increased: excess iron, liver disorders, megaloblastic anemia
Decreased: hemorrhage, iron-deficiency anemia
Total iron-binding capacity (TIBC)
Measurement of all proteins that bind or transport iron; indirect measure of transferrin
250-460 mcg/dL
Increased: iron-deficiency anemia
Decreased: anemia, hemorrhage
Serum ferritin
Body iron stores
10-300 ng/mL
Increased: excess iron, liver disorders, megaloblastic anemia
Decreased: hemorrhage, iron-deficiency anemia
Transferrin saturation
Measures available iron for erythropoiesis
Female: 15-50%
Male: 20-50%
Increased: hemolytic and megaloblastic anemia
Decreased: iron-deficiency anemia
Hemoglobin concentration lower than normal; decreased number of RBCs
Deficiency in # of RBCs, quality/quantity of Hgb or Hct
anemia
anemia types Categorized by morphology (color and size) or physiology (cause)
Hypoproliferative (decreased production)
Blood loss (bleeding)
Hemolysis (destruction of RBCs) - incompatibility
causes of anemia
impaired renal disease
bleeding
blood disorders
lack of iron in diet
medications
competition of minerals for absorption
clinical manifestation of anemia come from:
Depends on severity, coexisting disease, duration of anemia, metabolic requirements of the client, and development of anemia
The more rapidly it develops, the more severe its symptoms
May start to have symptoms when Hgb is 9-141 g/dL
Caused by reduced oxygen-carrying capacity; tissue hypoxia and compensatory mechanisms
clinical manifestations of anemia
weak, fatigue
dizziness
pica (cravings)
numbness and tingling
HA
Confusion
reflex abnormalities
loss of position
spasticity
roaring, rushing ,ringing in ears
pallor
jaundice
impaired wound healing
loss of elasticity
early thinning or greying of hair
palpitations
chest pain
tachy
hypotension
Peripheral edema
murmurs
dyspnea
tachypnea
orthopnea
anorexia
dysphagia
abdominal pain
hepatomegaly
splenomegaly
muscle pain
laboratory data of anemia
Hemoglobin
Hematocrit
Reticulocyte count
RBC indices
–Mean corpuscular volume (MCV)
–Red cell distribution (RDW)
Iron studies
Vitamin B12
Folate
Erythropoietin
Stool for H. Pylori and occult blood
diagnostic data of anemia
Bone marrow aspiration and biopsy - cancer?
Endoscopy - upper GI bleed
Colonoscopy - lower GI bleed
potential nursing problems for anemia
fatigue
ineffective health and management
ineffective tissue perfusion
impaired sensory perception
imbalanced nutrition: less than body requirements
impaired cardiac output
oxygenation
safety
fall prevention
nursing implementation for anemia
Investigate and fix the cause!
Acute therapy
–Supplemental 02
–IVF and/or Blood transfusion (for severe)
–Drug therapy - epogen - renal disease
–Monitor VS and labs
Energy conservation: Balance exercise and rest
Dietary/lifestyle changes
–Iron sources: organ meats, red meats, beans, leafy green veggies, raisins, molasses
–Vitamin C absorbs iron
Interprofessional collaboration
Patients with fatigue
Alternate rest and activity
Prioritize activities
Accommodate energy levels
Maximize O2 supply for vital functions
Provide assistance to minimize risk for injury
Evaluate nutritional needs
Arrange activities to reduce competition for oxygen supply to vital functions, for example avoiding activity immediately after meals.
Collaborate with the dietitian to determine calorie and nutrient needs to meet nutritional requirements.
Provide information and education about nutrition and how to meet patient’s intake of essential nutrients.
Encourage increased intake of foods high in iron.
causes of iron deficiency anemia
Results from blood loss,
poor GI absorption of iron (celiac or gastrectomy),
inadequate diet due to decreased iron,
hemolysis,
dialysis treatment,
alcoholism
s/s of IDA
weakness,
pallor,
fatigue,
glossitis,
cheilitis,
headache,
paresthesia,
burning sensation of the tongue
diagnostics of IDA
Monitor ferritin values,
Hgb and Hct,
RBC,
iron studies,
FOBT,
endoscopy/colonoscopy
drug therapy for IDA
Oral: ferrous sulfate or ferrous gluconate
IM/IV: sodium ferrous gluconate, iron sucrose, iron dextran
Side effects: nausea, constipation, green stools, epigastric discomfort (Oral); hypersensitivity
Nursing considerations
enteric coated do not absorb well - avoid
nursing management of IDA
Identification and treatment of cause
Drug therapy
Nutritional therapy
Examples??
PRBC transfusion
Emphasize compliance
Interprofessional collaboration
Verify therapeutic effect; manage side effects
treatment for IDA
increasing iron via food (red meat, organ meat, beets, dried beans, cream of wheat, iron-fortified cereals, egg yolks, dark leafy green vegetables, raisins);
ferrous sulfate PO (take b/w meals, stool color changes, constipation), IV, IM (Z-track, can stain skin)
administration considerations for iron
Iron is best absorbed as ferrous sulfate (Fe2+) in an acidic environment. For this reason and to avoid binding the iron with food, iron should be taken about an hour before meals, when the duodenal mucosa is most acidic. Taking iron with vitamin C (ascorbic acid) or orange juice, which contains ascorbic acid enhances iron absorption.
Undiluted liquid iron may stain teeth, thus the reason for ingesting it through a straw.
side effects of ferrous sulfate
Many individuals who need supplemental iron cannot tolerate ferrous sulfate because of the effects of the sulfate base. However, ferrous gluconate may be an acceptable substitute.
All patients need to be told that iron will cause their stools to become black because excess iron is excreted in the GI tract.
Because iron causes constipation, patients should be started on stool softeners and laxatives, if needed, when started on iron.
An iron-dextran complex (INFeD) contains 50 mg/mL of elemental iron in 2 mL. Sodium ferrous gluconate and iron sucrose are alternatives and may provide less risk of life-threatening anaphylaxis.
Because IM iron solutions may stain the skin, separate needles should be used for withdrawing the solution and for injecting the medication. A Z-track injection technique should be used.
teaching for administration of iron
Diet teaching
Supplemental iron
Discuss diagnostic studies
Emphasize compliance
Iron therapy for 2 to 3 months after Hgb levels return to normal